Contents:

1.1 List of Tables 1.2 List of Figures 2 Executive Summary 3 Global Glucose Monitoring Systems Market : Market Characterization 3.1 Overview 3.2 Glucose Monitoring Systems Market, Revenue ($ m), 2000 – 2008 3.3 Glucose Monitoring Systems Market, Revenue ($ m), 2008 – 2015 3.4 Glucose Monitoring Systems: Market Dynamics 3.4.1 Market Drivers 3.4.1.1 Increasing Prevalence of Diabetes to Boost Sales 3.4.1.2 Introduction of New Generation Devices to Drive the Glucose Monitoring Market 3.4.1.3 Home Healthcare to Boost Glucose Monitoring Market 3.4.1.4 Increasing Ageing and Obese Population Contributing to Diabetes Epidemic 3.4.1.5 Increasing Awareness about Diabetes, its Control and Related Complications to Drive the Market in Future 3.4.2 Market Restraints 3.4.2.1 High Cost and Reimbursement Hassles- a Growth Limiting Factor 3.4.2.2 Low Market Penetration Affecting Growth 3.4.2.3 Device Recalls Negatively Affect Physician and Patient Perceptions 3.5 Glucose Monitoring Systems: Perception Analysis 3.6 Glucose Monitoring Systems: Opportunities and Unmet Need 3.6.1 Major Unmet Needs 3.7 Key Takeaway 4 Global Glucose Monitoring Systems Market : Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Glucose Monitoring Systems Company Shares 2008 4.4 F. Hoffmann-La Roche Ltd 4.4.1 Diabetes Educational Programs by Roche 4.5 LifeScan (Johnson & Johnson) 4.5.1 Diabetes Educational Programs by Johnson & Johnson 4.6 Bayer Healthcare 4.6.1 Diabetes Educational Programs by Bayer Healthcare 4.7 Abbott Laboratories 4.7.1 Diabetes Educational programs by Abbott Labs 4.8 Product Profiles of the Major Marketed Products in the Glucose Monitoring Systems Market 4.8.1 Accu-Check Aviva 4.8.1.1 Overview 4.8.1.2 Efficacy 4.8.1.3 Safety Profile 4.8.1.4 Pricing 4.8.1.5 Clinical Trial Details 4.8.2 OneTouch Ultramini 4.8.2.1 Overview 4.8.2.2 Efficacy 4.8.2.3 Safety 4.8.2.4 Pricing 4.8.3 Contour Meter 4.8.3.1 Overview 4.8.3.2 Efficacy 4.8.3.3 Safety 4.8.3.4 Pricing 4.9 Key Takeaway 5 Global Glucose Monitoring Systems Market: Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Glucose Monitoring Systems – Pipeline by Clinical Stage of Development 5.4 Profiles of Promising Devices under Clinical Development 5.4.1 EyeSense Blood glucose measurement device 5.4.1.1 Overview 5.4.1.2 Efficacy 5.4.1.3 Safety 5.4.1.4 Clinical Study Detail 5.4.2 GlucoTrack 5.4.2.1 Overview 5.4.2.2 Efficacy 5.4.2.3 Safety 5.4.2.4 Clinical Study Details 5.4.3 LighTouch Monitor 5.4.3.1 Overview 5.4.3.2 Efficacy 5.4.3.3 Safety 5.5 Glucose Monitoring Systems Market: List of Pipeline Products 5.6 Glucose Monitoring Systems Pipeline Product Summary by Product Type 5.7 Glucose Monitoring Systems Pipeline Product Summary: Home Glucose Monitoring Systems 5.8 Glucose Monitoring Systems Pipeline Product Summary: Hospital Setting Glucose Monitoring Systems 5.9 Glucose Monitoring Systems Pipeline Product Summary: Both Home and Hospital Setting Glucose Monitoring Systems 5.10 Key Takeaway 6 Global Glucose Monitoring Systems Market : Implications for Future Market Competition 6.1 Strategic Competitor Assessment 7 Global Glucose Monitoring Systems Market: Emerging Companies 7.1 Introduction 8 Appendix 8.1 Definitions 8.1.1 Glucose Monitoring 8.1.1.1 Blood Glucose Meters 8.1.1.2 Blood Glucose Test Strips 8.2 Research Methodology 8.3 Secondary Research 8.4 Primary Research 8.5 Models 8.6 Forecasts 8.7 Expert Panels 8.8 GlobalData Consulting 8.9 Contact Us 8.10 Disclaimer 1.1 List of Tables Table 1: Glucose Monitoring Systems, Global, Revenue ($ m), 2000-2008 Table 2: Glucose Monitoring Systems, Global, Revenue ($ m), 2008-2015 Table 3: Prevalence Estimates of Diabetes, Global, 2030 Table 4: Prevalence of Diabetes (Diagnosed And Undiagnosed), By Age Group, US, 2007 Table 5: Prevalence of Diabetes (Diagnosed And Undiagnosed), By Gender, US, 2007 Table 6: Glucose Monitoring Systems Pipeline Product Summary - I Table 7: Glucose Monitoring Systems Pipeline Product Summary - II Table 8: Glucose Monitoring Systems Pipeline Product Summary - III Table 9: Home Glucose Monitoring Systems Pipeline Product Summary - I Table 10: Home Glucose Monitoring Systems Pipeline Product Summary - II Table 11: Hospital Setting Glucose Monitoring System Pipeline Product Summary Table 12: Home and Hospital Setting Glucose Monitoring Systems Pipeline Product Summary Table 13: Glucose Monitoring Systems Emerging Companies and Products- I Table 14: Glucose Monitoring Systems Emerging Companies and Products - II 1.2 List of Figures Figure 1: Glucose Monitoring Systems, Global, Revenue ($ m), 2000-2008 Figure 2: Glucose Monitoring Systems, Global, Revenue ($ m), 2008-2015 Figure 3: Diabetes Incidence by Diagnosis, US, 2007 Figure 4: Diabetic Population by Treatment Type, US, 2007 Figure 5: Glucose Monitoring Systems Perception Analysis Figure 6: Glucose Monitoring Systems, Opportunity and Unmet Need Figure 7: Strategic Competitive Assessment Figure 8: Glucose Monitoring Systems, Company Shares - 2008 Figure 9: Technology Trends Analytic Framework Figure 10: Technology Trends Analytic Framework - Descriptions Figure 11: Glucose Monitoring Systems – Pipeline by Clinical Stage of Development Figure 12: Glucose Monitoring Systems Pipeline Product by Product Type Figure 13: Strategic Competitor Assessment Figure 14: GlobalData Methodology

Companies Mentioned

- F. Hoffmann-La Roche Ltd - LifeScan (Johnson & Johnson) - Bayer Healthcare - Abbott Laboratories